Deanna Petersen
Net worth: 206 880 $ as of 29/06/2024
Profile
Deanna M.
Petersen's former job(s) include being a Director at American DG Energy, Inc. from 2010 to 2018, a Director at ArmaGen, Inc., an Independent Director at Tecogen, Inc. from 2017 to 2021, a Director-Technology Transfer at the University of Iowa, a Director at the Massachusetts Biotechnology Council, a Director at the Iowa Biotechnology Association, and a Director at the Iowa City Community School District Foundation (Iowa).
She was also the Vice President-Business Development at Agenus, Inc. from 2002 to 2009, the Vice President-Business Development at Coley Pharmaceutical Group, Inc. from 1998 to 2002, the Treasurer-Boston Chapter at the Healthcare Businesswomens Association, the VP-Development Rare Diseases Business at Shire Plc from 2009 to 2015, and the Vice President-Business Development at Shire Human Genetic Therapies, Inc. from 2009 to 2015.
Currently, she is the Chief Business Officer at Avrobio, Inc. from 2016 to 2023.
Ms. Petersen's education history includes an undergraduate degree from Iowa State University and an MBA from the University of Iowa.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.09% | 07/02/2023 | 12,561 ( 0.09% ) | 206 880 $ | 29/06/2024 |
Former positions of Deanna Petersen
| Companies | Position | End |
|---|---|---|
| TECTONIC THERAPEUTIC, INC. | Corporate Officer/Principal | 31/12/2022 |
| TECOGEN INC. | Director/Board Member | 28/03/2021 |
| AMERICAN DG ENERGY INC | Director/Board Member | 28/03/2018 |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Corporate Officer/Principal | 31/05/2015 |
| SHIRE | Corporate Officer/Principal | 31/05/2015 |
Training of Deanna Petersen
| University of Iowa | Masters Business Admin |
| Iowa State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| AGENUS INC. | Health Technology |
| TECOGEN INC. | Producer Manufacturing |
| Private companies | 10 |
|---|---|
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Health Technology |
Healthcare Businesswomens Association
 Healthcare Businesswomens Association Miscellaneous Commercial ServicesCommercial Services Healthcare Businesswomens Association operates women healthcare associations. The company was founded by Diane Anderson, Peg Dougherty, Millicent Gryczka, Sheila Sinkking and Ruth Smith in 1977 and is headquartered in Fairfield, NJ. | Commercial Services |
Iowa Biotechnology Association
 Iowa Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Iowa Biotechnology Association unifies Iowa''s bioscience industry, academic research institutions and economic development organizations. The firm encompasses development of industrial enzymes, livestock genetics, seed genetics, human gene research, nutraceuticals, pharmaceuticals, advanced bio-composites, biomass technologies and healthy foods/beverages. The company was founded in 1994 and is headquartered in Des Moines, IA. | Commercial Services |
| Iowa City Community School District Foundation (Iowa) | Government |
American DG Energy, Inc.
 American DG Energy, Inc. Building ProductsProducer Manufacturing American DG Energy, Inc distributes and produces electricity, heat, hot water and cooling equipment. It also provides natural gas powered cogeneration system. The company was founded by George N. Hatsopoulos and John N. Hatsopoulos on July 24, 2001 and is headquartered in Waltham, MA. | Producer Manufacturing |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Health Technology |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Commercial Services |
Avrobio, Inc.
 Avrobio, Inc. BiotechnologyHealth Technology AVROBIO, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. The firm's clinical-stage programs include Fabry, Gaucher Type 1, Hunter syndrome Gaucher Type 3, Pompe, and Cystinosis. The company was founded by Geoff Mackay, Kim Warren, Christopher Mason, and Jeffrey Medin in 2015 and is headquartered in Watertown, MA. | Health Technology |
ArmaGen, Inc.
 ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA. | Health Services |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Deanna Petersen
